Open AccessPoint of Care Test Technology Suitable for Early Detection and Monitoring of Ischemic Stroke
Author(s) -
Young Mi Lee,
Mi Jung Bae,
Ye Seul Choi,
Eun-Mi Lee,
Jung-Hwan Cho,
Myung-Gwan Kim,
Minh Tan Le,
Thi Hong Nguyen,
Hyung Soo Han,
Nora Jee-Young Park,
Gun Oh Chong
Publication year - 2021
Publication title -
current neurovascular research
Language(s) - English
Resource type - Journals
eISSN - 1875-5739
pISSN - 1567-2026
DOI - 10.2174/1567202618666211109103720
Subject(s) - detection limit , biomarker , medicine , stroke (engine) , point of care , myocardial infarction , coronary artery disease , antibody , whole blood , immunoassay , cardiology , pathology , immunology , chromatography , chemistry , mechanical engineering , biochemistry , engineering
Stroke is one of the leading causes of death and disability in adulthood worldwide. A simple and convenient diagnostic method is needed for monitoring high-risk patients for stroke. Few POCTs are available for stroke diagnosis. Soluble blood P-selectin is known as a biomarker for platelet aggregation. Increased expression of P-selectin is observed in coronary artery disease, acute myocardial infarction, stroke and peripheral arterial disease.